REVIVE THERAPEUTICS LTD.RR

REVIVE THERAPEUTICS LTD.

0.010CADR
0.0000.00%
At close at Feb 28, 22:10 GMT
CAD
No trades
See on Supercharts
Back

Diluted net income available to common stockholders of REVIVE THERAPEUTICS LTD.

Annual data
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
‪‪−22.00 M‬‬
‪‪−16.50 M‬‬
‪‪−11.00 M‬‬
‪‪−5.50 M‬‬
‪0.00‬
Period
Value
Change
Change %
TTM
‪‪−5.29 M‬‬
+‪‪324.03 K‬‬
+‪5.77‬%
2024
‪‪−5.62 M‬‬
+‪‪702.28 K‬‬
+‪11.11‬%
2023
‪‪−6.32 M‬‬
+‪‪11.49 M‬‬
+‪64.50‬%
2022
‪‪−17.81 M‬‬
+‪‪2.31 M‬‬
+‪11.49‬%
2021
‪‪−20.12 M‬‬
‪‪−14.74 M‬‬
‪−273.84‬%
2020
‪‪−5.38 M‬‬
‪‪−4.04 M‬‬
‪−300.46‬%
2019
2018
2017
2016
2015
Quarterly data
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪‪−2.80 M‬‬
‪‪−2.10 M‬‬
‪‪−1.40 M‬‬
‪‪−700.00 K‬‬
‪0.00‬
Period
Value
Change
Change %
Q2 '25
‪‪−364.71 K‬‬
+‪‪107.80 K‬‬
+‪22.82‬%
Q1 '25
‪‪−472.51 K‬‬
+‪‪2.11 M‬‬
+‪81.72‬%
Q4 '24
‪‪−2.59 M‬‬
‪‪−713.46 K‬‬
‪−38.11‬%
Q3 '24
‪‪−1.87 M‬‬
‪‪−1.10 M‬‬
‪−142.91‬%
Q2 '24
‪‪−770.62 K‬‬
‪‪−380.00 K‬‬
‪−97.28‬%
Q1 '24
‪‪−390.62 K‬‬
+‪‪801.94 K‬‬
+‪67.24‬%
Q4 '23
‪‪−1.19 M‬‬
+‪‪751.52 K‬‬
+‪38.66‬%
Q3 '23
‪‪−1.94 M‬‬
‪‪−419.13 K‬‬
‪−27.49‬%
Q2 '23
Q1 '23
Q4 '22
Q3 '22
Q2 '22
Q1 '22
Q4 '21
Q3 '21
Q2 '21
Q1 '21
Q4 '20
Q3 '20
Q2 '20
Q1 '20
Q4 '19
Q3 '19
Q2 '19
Q1 '19
Q4 '18
Q3 '18
Q2 '18
Q1 '18
Q4 '17